IPSEN, OOO
- Country
- 🇷🇺Russia
- Ownership
- -
- Established
- 1929-01-01
- Employees
- 5.7K
- Market Cap
- $9.8B
- Website
- https://www.ipsen.com/
A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development
- Conditions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 1051
- Registration Number
- NCT06055725
- Locations
- 🇬🇧
Nottingham University Hospitals NHS Trust - Nottingham City Hospital, Nottingham, United Kingdom
🇫🇷CHU Nantes, Saint-Jacques, France
🇮🇹Neuromotor And Cognitive Rehabilitation Research Centre; Dep. Of Neurological, Neuropsychological, Morphological And Movement Sciences; Univ. Of Verona - Neurological Rehabilitation Unit- Policlinico Borgo Roma, Verona, Italy
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 714
- Registration Number
- NCT06047457
- Locations
- 🇺🇸
840042, Miami, Florida, United States
🇺🇸840057, Kingwood, West Virginia, United States
🇺🇸840024, Birmingham, Alabama, United States
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 720
- Registration Number
- NCT06047444
- Locations
- 🇺🇸
840057, Kingwood, West Virginia, United States
🇺🇸840024, Birmingham, Alabama, United States
🇺🇸840018, Phoenix, Arizona, United States
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- Conditions
- Interventions
- First Posted Date
- 2023-08-30
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 276
- Registration Number
- NCT06016842
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
🇺🇸Southwest Gastroenterology Associates, PC (SWGA), Albuquerque, New Mexico, United States
A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET
- Conditions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 191
- Registration Number
- NCT05922579
- Locations
- 🇦🇺
CAPPRE, Sidney, Australia
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy
- Conditions
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 167
- Registration Number
- NCT05759273
- Locations
- 🇮🇹
Humanitas Gavazzeni, Bergamo, Italy
🇮🇹AOU Policlinico "Gaspare Rodolico", Catania, Italy
🇮🇹Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.
- Conditions
- Interventions
- First Posted Date
- 2022-11-25
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 68
- Registration Number
- NCT05627362
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Piedmont Hospital - Piedmont Transplant Institute, Atlanta, Georgia, United States
🇬🇧Aberdeen Royal Infirmary NHS Grampian Grampian Health Board, Aberdeen, United Kingdom
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
- Conditions
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 195
- Registration Number
- NCT05590793
- Locations
- 🇨🇳
Beijing Hospital, Beijing, China
🇨🇳Peking University People's Hospital, Beijing, China
🇨🇳Chongqing University Cancer Hospital, Chongqing, China
A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants After Intake of a Single Tablet
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 34
- Registration Number
- NCT05564208
- Locations
- 🇫🇷
BIOTRIAL, Rennes, France
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
- Conditions
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Ipsen
- Target Recruit Count
- 25
- Registration Number
- NCT05546190
- Locations
- 🇺🇸
Rancho Los Amigos National Rehab, Downey, California, United States
🇺🇸MedStar National Rehabilitation Network, Washington, District of Columbia, United States